Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongcheng Zhu

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Journal of Thoracic Disease|May 17, 2023
Immune characteristics and genetic markers of esophageal cancer by single-cell analysis: implications for immunotherapyBing Xu, Ihsuan Tseng, Xiaofei Zhang, et al.
Plos One|November 22, 2013
Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studiesQin Qin, Chi Zhang, Xi Yang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 24, 2014
Melittin enhances radiosensitivity of hypoxic head and neck squamous cell carcinoma by suppressing HIF-1αXi Yang, Hongcheng Zhu, Yangyang Ge, et al.
Acta Oto-Laryngologica|December 12, 2013
Berberine radiosensitizes human nasopharyngeal carcinoma by suppressing hypoxia-inducible factor-1α expressionChi Zhang, Xi Yang, Qu Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 23, 2017
eEF2K promotes progression and radioresistance of esophageal squamous cell carcinomaHongcheng Zhu, Hongmei Song, Guangzong Chen, et al.
Journal of Hematology & Oncology|August 21, 2014
Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repairQin Qin, Hongyan Cheng, Jing Lu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 31, 2014
Fenofibrate enhances radiosensitivity of esophageal squamous cell carcinoma by suppressing hypoxia-inducible factor-1α expressionYangyang Ge, Jia Liu, Xi Yang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 2, 2014
STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1αChi Zhang, Xi Yang, Qu Zhang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 31, 2013
Smac mimetic compound LCL161 sensitizes esophageal carcinoma cells to radiotherapy by inhibiting the expression of inhibitor of apoptosis proteinQin Qin, Yun Zuo, Xi Yang, et al.
Radiation Oncology (London, England)|October 19, 2023
Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organsIhsuan Tseng, Dashan Ai, Yun Chen, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Journal of Thoracic Disease|May 17, 2023
Immune characteristics and genetic markers of esophageal cancer by single-cell analysis: implications for immunotherapyBing Xu, Ihsuan Tseng, Xiaofei Zhang, et al.
Plos One|November 22, 2013
Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studiesQin Qin, Chi Zhang, Xi Yang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 24, 2014
Melittin enhances radiosensitivity of hypoxic head and neck squamous cell carcinoma by suppressing HIF-1αXi Yang, Hongcheng Zhu, Yangyang Ge, et al.
Acta Oto-Laryngologica|December 12, 2013
Berberine radiosensitizes human nasopharyngeal carcinoma by suppressing hypoxia-inducible factor-1α expressionChi Zhang, Xi Yang, Qu Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 23, 2017
eEF2K promotes progression and radioresistance of esophageal squamous cell carcinomaHongcheng Zhu, Hongmei Song, Guangzong Chen, et al.
Journal of Hematology & Oncology|August 21, 2014
Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repairQin Qin, Hongyan Cheng, Jing Lu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 31, 2014
Fenofibrate enhances radiosensitivity of esophageal squamous cell carcinoma by suppressing hypoxia-inducible factor-1α expressionYangyang Ge, Jia Liu, Xi Yang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 2, 2014
STAT3 inhibitor NSC74859 radiosensitizes esophageal cancer via the downregulation of HIF-1αChi Zhang, Xi Yang, Qu Zhang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 31, 2013
Smac mimetic compound LCL161 sensitizes esophageal carcinoma cells to radiotherapy by inhibiting the expression of inhibitor of apoptosis proteinQin Qin, Yun Zuo, Xi Yang, et al.
Radiation Oncology (London, England)|October 19, 2023
Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organsIhsuan Tseng, Dashan Ai, Yun Chen, et al.
Pageof 9